The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...

Earlier, in an exchange filing on October 7, the company said, "Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release - “Wockhardt's another breakthrough ...

In our hands-on review, we found Wix to be a "lean, efficient, and fast service which will have you create your logo and customize it to your heart’s content". We also noted that "Wix’s wealth ...

What makes a good AI logo? It’s a thorny question that every player in the current crop of leading AI companies has faced, since unlike an email app — which marries neatly with an envelope ...

After Jaslok and Wockhardt hospitals, a nurse in Breach Candy has tested positive for the novel coronavirus.With this, around 53 nurses and eight doctors have been affected across city hospitals ...

Wockhardt stock rose on October 7 after the US Food and Drug Administration granted it “fast track designation” for antibiotics used to treat urinary tract infections. WCK 6777 has also ...

Shares of Wockhardt Ltd jumped 4.32 per cent in Wednesday's trade to scale their one-year high value of Rs 1,127.25. The stock was last seen trading 1.71 per cent up at Rs 1,099. At this price ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

Drug firm Wockhardt on Friday said the national drug regulator has accorded a favourable recommendation for its novel antibiotic developed for the treatment of community-acquired bacterial ...

Drug firm Wockhardt has denied allegations regarding payment of rent by Carol Info Services and its connection with certain ...

Pharmaceuticals firm Wockhardt firmly denied recent allegations concerning rent payments made by its associate company, Carol ...

Shares of Wockhardt are locked at upper circuit after the pharma company said on September 19 that one of its investigational drug - Zaynich - has successfully treated critically ill patients of ...